Literature DB >> 10995878

A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.

P M Menon1, J A Gutierrez, S A Rempel.   

Abstract

SPARC is a secreted glycoprotein that interacts with extracellular matrix (ECM) proteins to promote de-adhesion of cells from the matrix, thereby inducing a biological state conducive to cell migration. We have demonstrated that SPARC is highly expressed in gliomas (grades II-IV) and promotes glioma invasion in vitro. Therefore, the protein itself or its mechanisms of action might become therapeutic targets to arrest glioma invasion. Vitronectin is an ECM protein found in the blood vessel basement membranes and may promote glioma invasion along these structures. It binds to SPARC in vitro. However, it is not known whether SPARC and vitronectin colocalize and/or interact to contribute to brain tumor cell migration in vivo. In this study, we immuno-histochemically determined if the grade I juvenile pilocytic astrocytomas (JPAs) also express SPARC, if vitronectin is expressed in grades I, II, and IV astrocytomas, and if the proteins colocalize in brain tumors in vivo. We performed western blot analyses to determine if different grades of tumors had different intracellular and/or secreted levels of SPARC and vitronectin. We performed migration assays to determine whether vitronectin is a permissive substrate for glioma migration, and whether the extent of migration correlates with the level of secreted SPARC. Our data demonstrated that JPAs expressed SPARC and secreted significantly higher levels than glioblastomas multiforme (GBMs). Vitronectin was absent from well-preserved tumor but present in areas of disrupted tumor, such as degeneration and/or necrosis. SPARC and vitronectin colocalized only in regions of angiogenesis. We observed that the extent of migration on vitronectin inversely correlated with the level of secreted SPARC: the higher the level, the lesser the migration. These data suggest that the outcome of SPARC - ECM interactions may depend on local SPARC concentrations. The high levels of SPARC secreted by the JPAs, paradoxically, may be more prohibitive for migration on vitronectin than the lower levels secreted by the GBMs. This may account, in part, for the lack of JPA invasion into brain tissue along blood vessel membranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995878     DOI: 10.3892/ijo.17.4.683

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.

Authors:  S A Rempel; W A Golembieski; J L Fisher; M Maile; A Nakeff
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

Authors:  Rolf A Brekken; Pauli Puolakkainen; David C Graves; Gail Workman; Sharon R Lubkin; E Helene Sage
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

3.  Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC.

Authors:  Hakan Kucukdereli; Nicola J Allen; Anthony T Lee; Ava Feng; M Ilcim Ozlu; Laura M Conatser; Chandrani Chakraborty; Gail Workman; Matthew Weaver; E Helene Sage; Ben A Barres; Cagla Eroglu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

4.  cDNA array analysis of SPARC-modulated changes in glioma gene expression.

Authors:  William A Golembieski; Sandra A Rempel
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

5.  RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells.

Authors:  Haiyan Liu; Yuanyuan Xu; Yun Chen; Haowen Zhang; Saijun Fan; Shuang Feng; Fenju Liu
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

6.  Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.

Authors:  Hai-Yun Wang; Yang-Yang Li; Qiong Shao; Jing-Hui Hou; Fang Wang; Man-Bo Cai; Yi-Xin Zeng; Jian-Yong Shao
Journal:  J Transl Med       Date:  2012-02-09       Impact factor: 5.531

7.  Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.

Authors:  C-S Wang; K-H Lin; S-L Chen; Y-F Chan; S Hsueh
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

8.  Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.

Authors:  Stacey L Thomas; Chad R Schultz; Ezekiell Mouzon; William A Golembieski; Reima El Naili; Archanna Radakrishnan; Nancy Lemke; Laila M Poisson; Jorge A Gutiérrez; Sandra Cottingham; Sandra A Rempel
Journal:  Brain Pathol       Date:  2015-04-20       Impact factor: 6.508

9.  The role of astrocyte-secreted matricellular proteins in central nervous system development and function.

Authors:  Cagla Eroglu
Journal:  J Cell Commun Signal       Date:  2009-11-11       Impact factor: 5.782

10.  SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.

Authors:  Christopher K Yunker; William Golembieski; Nancy Lemke; Chad R Schultz; Simona Cazacu; Chaya Brodie; Sandra A Rempel
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.